Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$246,948
-$108,195 QoQ
Shares Held
72,632
+2.5% QoQ
Ownership
0.806%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. LSTA ranks #391 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in LSTA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $246,948 72,632
2026-03-31 $355,143 70,887
2025-12-31 $119,835 64,428
2025-09-30 $165,740 63,260
2025-06-30 $177,137 61,082
2025-03-31 $142,243 60,529
2024-12-31 $166,566 55,895
2024-09-30 $167,043 55,681
2024-06-30 $176,615 50,898
2024-03-31 $138,372 44,350
2023-12-31 $118,454 43,390
2023-09-30 $92,854 43,390
2023-06-30 $96,100 25,973
2023-03-31 $84,412 25,973
2022-12-31 $65,711 25,973
2022-09-30 $120,555 26,038